Confronting the Remdesivir Shortage

By Dr. Brian Abrahams
Published May 18, 2020 | 4 min watch

Watch CNBC’s Meg Tirrell talks to Dr. Brian Abrahams, Co-Head of Biotechnology Research at RBC Capital Markets, about the supply of the coronavirus-fighting drug remdesivir.

Dr. Brian Abrahams

Dr. Brian Abrahams
Co-Head of Biotechnology Research,


BiotechnologyBrian AbrahamRemdesivir